Kinnate Biopharma Inc. Quarterly Common Stock, Shares, Issued from Q4 2020 to Q4 2023

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Kinnate Biopharma Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2020 to Q4 2023.
  • Kinnate Biopharma Inc. Common Stock, Shares, Issued for the quarter ending December 31, 2023 was 47.1M shares, a 6.27% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 47.1M +2.78M +6.27% Dec 31, 2023 10-K 2024-03-28
Q3 2023 47.1M +2.95M +6.68% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 47.1M +2.95M +6.7% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 46.6M +2.61M +5.95% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 44.3M +486K +1.11% Dec 31, 2022 10-K 2024-03-28
Q3 2022 44.2M +482K +1.1% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 44.1M +474K +1.09% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 44M +479K +1.1% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 43.9M +379K +0.87% Dec 31, 2021 10-K 2023-03-15
Q3 2021 43.7M Sep 30, 2021 10-Q 2021-11-10
Q2 2021 43.6M Jun 30, 2021 10-Q 2021-08-16
Q1 2021 43.5M Mar 31, 2021 10-Q 2021-05-17
Q4 2020 43.5M Dec 31, 2020 10-K 2022-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.